Oleochem Analytics — Royal DSM, headquartered in the Netherlands, announced that it will acquire the flavor and fragrance bio-based intermediates business of Amyris for $150 million.
DSM will acquire the business currently consisting of seven intermediate products which will be added to DSM’s existing Personal Care & Aroma Ingredients activities.
The acquisition extends DSM’s offerings in Aroma Ingredients with bio-based ingredients for the flavor and fragrance and cosmetics industries.
In November 2017, DSM acquired Amyris’ Farnesene business and technology for nutritional and flavor and fragrance ingredients, as well as its Brotas biotechnology manufacturing facilities in Brazil.
According to DSM the acquisition further strengthens the company’s biotechnology base with flavor and fragrance intermediate products and increases the scale of DSM’s biotechnology activities in nutritional ingredients.
